ApniCure wins FDA clearance for sleep apnea device

ApniCure Inc. can go ahead with marketing a sleep device in the United States after the Food and Drug Administration cleared the product.

The privately held Redwood City company said Friday that its Winx Sleep Therapy System -- using a light, oral vacuum and a slim tube connected to a soft, flexible mouthpiece -- will launch in select markets this year. It is designed for people with obstructive sleep apnea.